Home >> Marketplace Archives >> iBio, TheoremDx partnership, 11/17

iBio, TheoremDx partnership, 11/17

Print Friendly, PDF & Email


November 2017—iBio has partnered with TheoremDx to develop proteins for rapid diagnostic testing products. The collaboration will leverage the TheoremDx point-of-care diagnostic system and the protein development and manufacturing capabilities of iBio to develop and manufacture proprietary plant proteins for point-of-care diagnostic testing products. The initial focus is on developing tests to identify and distinguish specific neglected tropical diseases, such as Zika, dengue, chikungunya, and West Nile, from one another and to create a next-generation HIV test.

iBio, 646-277-1282